Leslie Trigg Outset Medical, Inc. (OM) insider trading activity

Leslie Trigg is Chair and CEO of Outset Medical, Inc.. Currently has a direct ownership of 915,804 shares of OM, which is worth approximately $3.53 Million. The most recent transaction as insider was on Jan 03, 2022, when has been sold 42,500 shares (Common Stock) at a price of $3.88 per share, resulting in proceeds of $164,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 916K

0.37% 3M change

123.65% 12M change

Total Value Held $3.53 Million

Leslie Trigg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2022	BUY Exercise of conversion of derivative security	$164,900 $3.88 p/Share	42,500 Added 14.02%	260,567 Common Stock
Dec 01 2021	SELL Open market or private sale	$944,800 $47.24 p/Share	20,000 Reduced 7.39%	250,567 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$68,200 $3.41 p/Share	20,000 Added 7.24%	256,194 Common Stock
Nov 01 2021	SELL Open market or private sale	$1,968,400 $56.24 p/Share	35,000 Reduced 12.26%	250,567 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$102,550 $2.93 p/Share	35,000 Added 11.64%	265,567 Common Stock
Oct 01 2021	SELL Open market or private sale	$2,069,750 $48.7 p/Share	42,500 Reduced 14.5%	250,567 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$124,525 $2.93 p/Share	42,500 Added 14.02%	260,567 Common Stock

Sep 17 2021	SELL Open market or private sale	$825,000 $55.0 p/Share	15,000 Reduced 5.65%	250,567 Common Stock
Sep 17 2021	BUY Exercise of conversion of derivative security	$43,950 $2.93 p/Share	15,000 Added 5.35%	265,567 Common Stock
Sep 01 2021	SELL Open market or private sale	$983,200 $49.16 p/Share	20,000 Reduced 7.4%	250,257 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$58,600 $2.93 p/Share	20,000 Added 7.27%	255,257 Common Stock
Aug 02 2021	SELL Open market or private sale	$812,400 $40.62 p/Share	20,000 Reduced 7.4%	250,257 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$58,600 $2.93 p/Share	20,000 Added 6.89%	270,257 Common Stock
Jul 01 2021	SELL Open market or private sale	$2,093,125 $49.25 p/Share	42,500 Reduced 14.5%	250,658 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$105,400 $2.48 p/Share	42,500 Added 13.88%	263,739 Common Stock
Jun 01 2021	SELL Open market or private sale	$958,000 $47.9 p/Share	20,000 Reduced 7.39%	250,658 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$22,200 $1.11 p/Share	20,000 Added 6.88%	270,658 Common Stock
May 03 2021	SELL Open market or private sale	$1,175,800 $58.79 p/Share	20,000 Reduced 7.39%	250,658 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$22,200 $1.11 p/Share	20,000 Added 6.88%	270,658 Common Stock
Apr 01 2021	SELL Open market or private sale	$3,183,775 $55.37 p/Share	57,500 Reduced 18.66%	250,658 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$63,825 $1.11 p/Share	57,500 Added 15.73%	308,158 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	87,412 Added 25.86%	250,658 Common Stock

Also insider at

ADPT

Adaptive Biotechnologies Corp Healthcare

Director

Leslie Trigg

Chair and CEO

San Jose, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OM shares.

Notify only if

Value

Insider Trading

Get notified when an Outset Medical, Inc. insider buys or sells OM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Outset Medical, Inc.

Track Activities on OM

Account